Clinical Development Innovation: Decentralised Trials, AI-Optimised Protocol Design, and Real-Time Analytics
The full version of this content, along with thousands of articles and analysis reports, can be found here: Clinical Development Innovation: Decentralised Trials, AI-Optimised Protocol Design, and Real-Time Analytics The economics of drug development remain unforgiving. Despite decades of scientific progress, the average timeline from first-in-human dosing to regulatory approval still spans close to a decade, while the fully loaded cost per approved asset frequently exceeds £1.5 billion when accounting for attrition. Phase III failure rates remain stubborn, protocol complexity has risen, and site-level […] This content was published by Platform Executive . If you enjoy the content then please post a link, or share on social media to help us. Clinical Development Innovation: Decentralised Trials, AI-Optimised Protocol Design, and Real-Time Analytics posted first on https://www.platformexecutive.com/